Sodium glucose co-transport 2 inhibitors in the treatment of type 2 diabetes mellitus: a meta-analysis of randomized double-blind controlled trials

BACKGROUND: The discovery of sodium-glucose co-transporter 2 (SGLT2) inhibitors, with a novel mechanism independent of insulin secretion or sensitization, bring about a new therapeutic approach to the management of type 2 diabetes mellitus. The aim of this meta-analysis was to evaluate the safety an...

Descripción completa

Detalles Bibliográficos
Autores principales: Berhan, Asres, Barker, Alex
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883465/
https://www.ncbi.nlm.nih.gov/pubmed/24341330
http://dx.doi.org/10.1186/1472-6823-13-58

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883465/
https://www.ncbi.nlm.nih.gov/pubmed/24341330
http://dx.doi.org/10.1186/1472-6823-13-58

Ejemplares similares